Pfizer CEO states that the company plans to conduct approximately 20 clinical trials related to weight loss drugs by 2026. (Cailian Press)
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Pfizer CEO: Plans to conduct approximately 20 clinical trials related to weight loss drugs by 2026
Pfizer CEO states that the company plans to conduct approximately 20 clinical trials related to weight loss drugs by 2026. (Cailian Press)